HomeERMA • STO
add
Enorama Pharma AB
Previous close
kr 4.00
Day range
kr 3.91 - kr 4.69
Year range
kr 1.68 - kr 8.48
Market cap
180.91M SEK
Avg Volume
11.60K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 5.66M | 1,137.64% |
Operating expense | 8.94M | -0.71% |
Net income | -6.77M | 13.55% |
Net profit margin | -119.64 | 93.02% |
Earnings per share | — | — |
EBITDA | -5.66M | 29.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.38M | 6,934.82% |
Total assets | 49.72M | 48.95% |
Total liabilities | 10.96M | -46.91% |
Total equity | 38.75M | — |
Shares outstanding | 60.47M | — |
Price to book | 6.25 | — |
Return on assets | -37.44% | — |
Return on capital | -54.79% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -6.77M | 13.55% |
Cash from operations | -12.60M | -696.15% |
Cash from investing | — | — |
Cash from financing | 25.54M | 4,974.62% |
Net change in cash | 13.19M | 715.64% |
Free cash flow | -10.04M | -701.59% |
About
Founded
2006
Website
Employees
5